Back to Browse Journals » Research Reports in Clinical Cardiology » Volume 4

Galectin-3: clinical utility and prognostic value in patients with heart failure

Authors Kramer F

Published Date February 2013 Volume 2013:4 Pages 13—22

DOI http://dx.doi.org/10.2147/RRCC.S28562

Received 6 December 2012, Accepted 3 January 2013, Published 7 February 2013

Frank Kramer

Clinical Sciences, Global Biomarker Strategy and Development, Bayer HealthCare, Wuppertal, Germany

Abstract: This review summarizes the key findings of 14 clinical trials in which Galectin-3 was assessed as a biomarker of heart failure. In addition, most relevant information available about Galectin-3 biology generated in in vitro and in vivo research is discussed in the context of heart failure.

Keywords: biomarker, cardiovascular disease, therapy monitoring, prediction of outcome, patient stratification

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Recovery in ERG gene expression with biventricular pacing in a rabbit model of myocardial infarction

Saba S, Mehdi H, Barrington W, Mehdi F, Islam Z, London B

Research Reports in Clinical Cardiology 2013, 4:61-66

Published Date: 21 May 2013

Transitioning from population to individualized preventive cardiology

Morris PB, Wright RF

Research Reports in Clinical Cardiology 2013, 4:55-59

Published Date: 10 April 2013

Resolute Integrity drug eluting stent safety and efficacy for the treatment of coronary artery disease

Burgos JD, Farrag S, Mukherjee D

Research Reports in Clinical Cardiology 2013, 4:23-37

Published Date: 22 February 2013

Coronary arterial complications after percutaneous coronary intervention in Behçet’s disease

Kinoshita T, Fujimoto S, Ishikawa Y, Yuzawa H, Fukunaga S, Toda M, Wagatsuma K, Akasaka Y, Ishii T, Ikeda T

Research Reports in Clinical Cardiology 2013, 4:9-12

Published Date: 5 February 2013

A novel porcine model of early left ventricular dysfunction for translational research

Malik N, Farrell KA, Withers SB, Wright EJ, Holt CM

Research Reports in Clinical Cardiology 2013, 4:1-7

Published Date: 25 January 2013

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010